Company news

Pfizer Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Pfizer: Audited Results - Year ended March 31, 2026

May 12, 2026

Pfizer: Unaudited Results – Quarter ended December 31, 2025

February 9, 2026

Press Release Dec 19 2025

December 19, 2025

Pfizer: & Cipla Announce Exclusive Marketing and Distribution Partnership for Select Brands in India

December 18, 2025

Annual Return – 2024-25

September 23, 2025

Pfizer: Unaudited Results – Quarter Ended June 30, 2025

August 13, 2025

Press Release Aug 11 2025

August 11, 2025

Draft Annual Return 2024-25

June 30, 2025

Pfizer: Audited Results - Year ended March 31, 2025

May 20, 2025

Pfizer: Unaudited Results – Quarter ended December 31, 2024

February 2, 2025

Pfizer: Integrated filing (Financial) for the quarter ended December 31, 2024

January 30, 2025

Annual Return 2023-24

November 15, 2024

Pfizer: Unaudited Results – Quarter ended September 30, 2024

October 28, 2024

Pfizer: Unaudited Results – Quarter ended June 30, 2024

August 21, 2024

Annual Report 2023 – 24

August 6, 2024

Pfizer: Audited Results – Year ended March 31, 2024

May 18, 2024

Annual Return 2022 – 23

October 17, 2023

Press Release Feb 09 2023

February 9, 2023

Pfizer Launches ‘Pfizer PAP India’, an assistance app for Indian patients

December 15, 2022

Press Release May 26 2021

May 26, 2021

Press Release Nov 02 2020

November 2, 2020

Company Announcement: Revised Book Closure Intimation

June 25, 2015

Pfizer revenues (on a like to like basis) increases by 12% for the year ended March 31, 2015.

May 7, 2015

February 14, 2015 - Pfizer Limited revenues (on a like to like basis and net of transition support sales) increased by 16% for the quarter and 14% for the nine months ended December 31, 2014.

February 23, 2015

Company Announcement: Approval for trading of 1,59,06,292 additional shares of Pfizer Limited

January 12, 2015

December 1st,2014: Press Note

December 6, 2014

December 3, 2014: Notice of Record Date

December 3, 2014

Pfizer revenues (net of transition support sales) increased by 7% for the quarter and 8% for the half year ended September 30, 2014

November 6, 2014

Decks